Germany · Delayed Price · Currency is EUR Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of EUR 59.06 billion. The enterprise value is 68.36 billion.
| Market Cap | 59.06B |
| Enterprise Value | 68.36B |
Important Dates
The next confirmed earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | Apr 27, 2026 |
Share Statistics
Merck KGaA has 434.78 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 129.24M |
| Shares Outstanding | 434.78M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 14.77% |
| Float | 129.21M |
Valuation Ratios
The trailing PE ratio is 24.93 and the forward PE ratio is 15.66. Merck KGaA's PEG ratio is 2.21.
| PE Ratio | 24.93 |
| Forward PE | 15.66 |
| PS Ratio | 2.79 |
| PB Ratio | 1.95 |
| P/TBV Ratio | 14.21 |
| P/FCF Ratio | 21.68 |
| P/OCF Ratio | 13.96 |
| PEG Ratio | 2.21 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.24, with an EV/FCF ratio of 25.09.
| EV / Earnings | 28.84 |
| EV / Sales | 3.23 |
| EV / EBITDA | 12.24 |
| EV / EBIT | 18.37 |
| EV / FCF | 25.09 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.41.
| Current Ratio | 1.69 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 2.20 |
| Debt / FCF | 4.52 |
| Interest Coverage | 9.08 |
Financial Efficiency
Return on equity (ROE) is 8.13% and return on invested capital (ROIC) is 7.55%.
| Return on Equity (ROE) | 8.13% |
| Return on Assets (ROA) | 4.65% |
| Return on Invested Capital (ROIC) | 7.55% |
| Return on Capital Employed (ROCE) | 8.35% |
| Weighted Average Cost of Capital (WACC) | 7.63% |
| Revenue Per Employee | 340,141 |
| Profits Per Employee | 38,142 |
| Employee Count | 62,136 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.85 |
Taxes
In the past 12 months, Merck KGaA has paid 647.00 million in taxes.
| Income Tax | 647.00M |
| Effective Tax Rate | 21.35% |
Stock Price Statistics
The stock price has increased by +22.64% in the last 52 weeks. The beta is 0.81, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +22.64% |
| 50-Day Moving Average | 140.32 |
| 200-Day Moving Average | 126.07 |
| Relative Strength Index (RSI) | 35.01 |
| Average Volume (20 Days) | 206,595 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of EUR 21.14 billion and earned 2.37 billion in profits. Earnings per share was 5.45.
| Revenue | 21.14B |
| Gross Profit | 12.49B |
| Operating Income | 3.72B |
| Pretax Income | 3.03B |
| Net Income | 2.37B |
| EBITDA | 5.59B |
| EBIT | 3.72B |
| Earnings Per Share (EPS) | 5.45 |
Balance Sheet
The company has 3.12 billion in cash and 12.30 billion in debt, with a net cash position of -9.18 billion or -21.11 per share.
| Cash & Cash Equivalents | 3.12B |
| Total Debt | 12.30B |
| Net Cash | -9.18B |
| Net Cash Per Share | -21.11 |
| Equity (Book Value) | 30.29B |
| Book Value Per Share | 69.58 |
| Working Capital | 5.64B |
Cash Flow
In the last 12 months, operating cash flow was 4.23 billion and capital expenditures -1.51 billion, giving a free cash flow of 2.72 billion.
| Operating Cash Flow | 4.23B |
| Capital Expenditures | -1.51B |
| Depreciation & Amortization | 1.87B |
| Net Borrowing | 2.69B |
| Free Cash Flow | 2.72B |
| FCF Per Share | 6.27 |
Margins
Gross margin is 59.09%, with operating and profit margins of 17.61% and 11.21%.
| Gross Margin | 59.09% |
| Operating Margin | 17.61% |
| Pretax Margin | 14.34% |
| Profit Margin | 11.21% |
| EBITDA Margin | 26.43% |
| EBIT Margin | 17.61% |
| FCF Margin | 12.89% |
Dividends & Yields
This stock pays an annual dividend of 2.20, which amounts to a dividend yield of 1.59%.
| Dividend Per Share | 2.20 |
| Dividend Yield | 1.59% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 43.80% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 1.59% |
| Earnings Yield | 4.01% |
| FCF Yield | 4.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Merck KGaA is 153.50, which is 13.62% higher than the current price. The consensus rating is "Buy".
| Price Target | 153.50 |
| Price Target Difference | 13.62% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 4.16% |
| EPS Growth Forecast (3Y) | 5.68% |
Stock Splits
The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Jun 30, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Merck KGaA has an Altman Z-Score of 2.79 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.79 |
| Piotroski F-Score | 6 |